INGREDIENTS
INGREDIENTS:
Lactobacillus rhamnosus:
- Along with B. breve, and P. freudenreichii, may support higher seroconversion rates of Hib IgG at 6 months with vaccination. †
- Along with B. longum, may support increased hepatitis B vaccine IgG levels. †
- Modulates Th1- and Th2- immune response markers. †
- Supports intestinal epithelial homeostasis and modulation of cytokines in vitro. †
- Important in the normal maturation of an infant’s and child’s immune system. †
- Supports normal bowel function in children. †
Lactobacillus casei:
- May support higher number of rotavirus IgM secreting cells and higher seroconversion rates for rotavirus IgA 8d after vaccination. †
- Critical for the proper differentiation of immune dendritic cells as the infant’s immune system learns to distinguish between harmless antigens and toxins and undesirable microorganisms. †
- Increases the number of intestinal cells secreting IgA (gut immune system), supporting innate immune responses to immunological challenges. †
- Contains enzymes that facilitate and break down milk proteins and gluten. †
- Supports a healthy balance between the Th1 and Th2 parts of the immune system. †
Lactobacillus paracasei:
- May support higher diphtheria IgG levels at 6.5 and 12 months after vaccination. †
- Produces high amounts of L(+)-lactic acid that can be safely metabolized by infants, small children, and the most sensitive individual. †
- Excellent acid-tolerance in the stomach; highly resistant to pepsin and pancreatin.
Lactobacillus salivarius:
- Enhances calcium uptake by intestinal-like cells in culture.
- May beneficially modulate interleukin production and balance. †
- May work synergistically with B. breve to modulate interleukins. †
Bifidobacterium infantis:
- Along with B. bifidum, B. longum, and L. acidophilus, may support higher total IgG level response when supplementing 2 months pre-vaccination and 3 months post MMRV vaccination. †
- Found in infant and children intestinal tracts, rarely found in adults.
- Supports healthy bacterial balance in premature or low birth weight babies. †
- Supports cytokine balance.
- Promotes healthy microbiota and stool consistency in children. †
Bifidobacterium bifidum:
- Along with B. infantis, B. longum, and L. acidophilus, may support higher total IgG level response when supplementing 2 months pre-vaccination and 3 months post MMRV vaccination. †
- Suppresses total and allergen-specific IgE secretion. †
- Second most prominent species identified in breast-fed infants.
- Produces a suite of enzymes dedicated to the metabolism of human milk oligosaccharides (HMO). †
- May affect regulation of NF-KB signaling pathways, supporting healthy epithelial cells. †
Bifidobacterium longum:
- Along with B. infantis, B. bifidum, and L. acidophilus, may support higher total IgG level response when supplementing 2 months pre-vaccination and 3 months post MMRV vaccination. †
- Regulates the immune response to respiratory stimuli and inhibits neutrophil elastase, which is important to normal innate immune functions. †
- Often the dominant Bifido species found in humans.
Bifidobacterium breve:
- May promote healthy antibody response to an oral vaccine. †
- Along with L. rhamnosus, and P. freudenreichii, may support higher seroconversion rates of Hib IgG at 6 months with vaccination. †
- Promotes growth of B cells in Peyer’s patches in the ileum.
- Commonly found in the gut of neonates and breastfed infants.
